1. Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion
- Author
-
C M, Buchanan, A R, Phillips, and G J, Cooper
- Subjects
Male ,endocrine system ,Secretory Vesicles ,Molecular Sequence Data ,Down-Regulation ,Cell Separation ,In Vitro Techniques ,Antibodies ,Peptide Fragments ,Cell Line ,Rats ,Perfusion ,Islets of Langerhans ,Mice ,Glucose ,Insulin-Like Growth Factor II ,Insulin Secretion ,Animals ,Humans ,Insulin ,Amino Acid Sequence ,Protein Precursors ,Rats, Wistar ,Research Article - Abstract
Pancreatic islet beta-cells secrete the hormones insulin, amylin and pancreastatin. To search for further beta-cell hormones, we purified peptides from secretory granules isolated from cultured murine beta TC6-F7 beta-cells. We identified a 34-amino-acid peptide (3948 Da), corresponding to Asp(69)-Leu(102) of the proinsulin-like growth factor II E-peptide, which we have termed 'preptin'. Preptin, is present in islet beta-cells and undergoes glucose-mediated co-secretion with insulin. Synthetic preptin increases insulin secretion from glucose-stimulated beta TC6-F7 cells in a concentration-dependent and saturable manner. Preptin infusion into the isolated, perfused rat pancreas increases the second phase of glucose-mediated insulin secretion by 30%, while anti-preptin immunoglobulin infusion decreases the first and second phases of insulin secretion by 29 and 26% respectively. These findings suggest that preptin is a physiological amplifier of glucose-mediated insulin secretion.
- Published
- 2001